Navigation Links
Key Pharma Diagnostics and Life Sciences Industry Expertise Added to Board of Directors of Modern Mobility Aids, Inc. (MDRM.OB)
Date:10/13/2011

TORONTO, Oct. 13, 2011 /PRNewswire/ -- Modern Mobility Aids, Inc. (OTC BB: MDRM) (the "Company"), headquartered in Nevada, USA, is adding Darshna Tanna to its Board of Directors. Ms. Tanna's appointment follows the recent announcement of Mr. Ferman Naqvi's, CA, appointment to the Board.  Ms. Tanna's extensive global work experience will help to build the Company's competitive growth in North American and International markets based on her demonstrated track record of generating outstanding business results in diverse cultural and organizational settings worldwide.

Ms. Tanna is currently the Asia-Pacific Regional Director of BioMerieux, a global leader in the field of in-vitro diagnostics. Directly involved in key accounts, new product development as well as management and communications with a network of distributors, she also plays an instrumental role in creating the efficient, highly skilled and motivated team of business managers to build the business in local markets and to grow top-line revenues.

In the past, Ms. Tanna also occupied senior managerial and account positions at Organon Teknika (North America), a biopharmaceutical company engaging in the manufacturing and marketing of prescription medicines primarily in the areas of gynecology, fertility, neuroscience, and anesthesia.  

Commenting on the Company's business evolution, which focuses on the increasing demand from the global pharmaceutical and life sciences industries for innovative delivery and packaging formats, Ms. Tanna remarks, "Developing alternative health care solutions to broaden drug delivery and device packaging options will help to prolong the commercial life of patented medications. For example, moving from a pill to a metered-dose, injectable format or a transdermal patch or an inhaler."  

Mohamed K. Karatella, President and CEO of Modern Mobility Aids, Inc. adds, "Instead of just focusing on commodity manufacturing capacity, such value-added innovation for existing products marketed by larger pharmaceutical firms will sustain our competitive differentiation. We are excited to have Ms. Tanna on board and are certain her vision and experience will accelerate our foray into new markets."

About Modern Mobility Aids, Inc.

Modern Mobility Aids, Inc. was first incorporated under the laws of the State of Nevada on December 19, 2007, under the name of Glider Inc. Its business plan was to sell and distribute products for mobility-challenged individuals. The Company changed its name to Modern Mobility Aids, Inc. on April 22, 2010 with initial plans to distribute products for mobility-challenged individuals. In May of 2011, the business focus of the Company evolved with a rapid expansion strategy in the life sciences and healthcare industry.  A mandate was created to acquire companies within the biopharma sector, targeting innovative research and development as well as scalable manufacturing capacity in three niche market segments: CRAM (Contract Research and Manufacturing for Life Sciences Companies), HEALTHCARE INNOVATION (Novel Drug and Device Delivery Format Packaging) and BIOPHARMA PARTNERSHIPS (Strategic Development and Production Alliances).

Safe Harbor

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) potential acquisitions, (iii) trends affecting its financial condition or results of operations; (iv) growth strategy and operating strategy. The words "may," "would," "will," "expect, "intend," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in the Company's filings with the Securities and Exchange Commission.

CONTACT INFO:
Modern Mobility Aids, Inc.
Public Relations and Shareholder Information:   investor@mdrmgroup.com


'/>"/>
SOURCE Modern Mobility Aids, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
2. PharmAthene Submits Legal Brief in Response to SIGA Technologies Motion for Reargument
3. K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P
4. Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Amylin Pharmaceuticals to Webcast Third Quarter Results
7. Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
8. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
9. Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA)
10. Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011
11. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... January 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, ... The global anti-obesity drugs market is expected ... of the forecast period and CAGR of 38.7% in the second ... at a CAGR of 32.8% from 2016 to 2027. The market ... and $24,063 million in 2027. ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017 Accuray ... its CyberKnife® and TomoTherapy® Systems continue to set the ... received the highest composite overall user satisfaction rating among ... the Q4 2016 MD Buyline Market Intelligence Briefing™. The ... the highest composite ratings among industry peers for 11 ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Allegheny Health Network (AHN) officials today announced a ... the Network’s programs and services in the greater Pittsburgh region. Starting January 23, patients ... offered one for that same afternoon. , AHN is the first ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... asset protection and financial planning services to communities throughout eastern Georgia, is embarking ... against heart disease. , Heart disease kills more Americans every year than anything ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... owned insurance agency which serves Lawrenceville, New Jersey and the surrounding area, ... , Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or ...
(Date:1/19/2017)... ... ... Attorney Robert “RC” Pate , founder of The Law Office of ... Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. In 2006, ... of the critical funding gap for research into pediatric cancer research. From 2006 onwards, ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second ... Associates of Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. ... have each been chosen by their peers for the 2017 list based on ...
Breaking Medicine News(10 mins):